New findings show that abnormal sleep durations, either too short or too long, significantly elevate the risk of microvascular complications in newly diagnosed type 2 diabetes patients. Credit: SciTechDaily.com Abnormal sleep patterns, particularly shorter or longer than the optimal 7-9 hours, are linked to increased microvascular disease risks in people with newly diagnosed type 2 diabetes, suggesting a need for targeted sleep interventions.
New research to be presented at this year’s Annual Meeting of the European Association for the Study of Diabetes (EASD) (Madrid, September 9-13) shows that people recently diagnosed with diabetes who experience short or long sleep duration are more likely to experience microvascular disease (damage to the small blood vessels), which could ultimately lead to more serious complications. The study is by Mette Johansen and Thomas Olesen, Steno Diabetes Center Odense, Odense University Hospital, Odense, Denmark, and colleagues. Study Details and Methodology Microvascular complications, such as retinopathy and nephropathy, are major contributors to complications associated with type 2 diabetes (T2D).
Increasing evidence suggests that variations in sleep duration may influence the risk of developing diabetes-related complications. This study aimed to explore the relationship between sleep duration and the presence of microvascular disease in individuals newly diagnosed with T2D. Sleep Measurement and Classification For their analysis, the aut.
